insights_auto
Why is GOVX down 3.56%?
Dive Deeperchevron_right
GOVX:NASDAQ
Geovax Labs Inc
$0.32
arrow_downward
-3.56%(-0.012) 1D
$0.32
arrow_downward
-0.62% (-0.0020)bedtimeAfter hours
Closed: Oct 1, 4:00:01āÆPM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GOVX...
Open
$0.33
High
$0.34
Low
$0.32
Mkt. cap
2.97M
Avg. vol.
952.21K
Volume
123.87K
52-wk high
$15.75
52-wk low
$0.32
EPS
-$13.92
Beta
3.66
Shares outstanding
10.10M
No. of employees
19
Open
$0.33
High
$0.34
Low
$0.32
Mkt. cap
2.97M
Avg. vol.
952.21K
Volume
123.87K
52-wk high
$15.75
52-wk low
$0.32
EPS
-$13.92
Beta
3.66
Shares outstanding
10.10M
No. of employees
19
News stories
From web sources and news partners
Investing.com
·
51 minutes ago
Twilio to join S&P 500 as S&P Dow Jones reshuffles indices
ChartMill
·
3 hours ago
What's going on in today's session: S&P500 movers
marketscreener.com
·
1 hour ago
S&P 500 Snaps 3-Day Losing Streak as Yields Fall
24/7 Wall St.
·
2 hours ago
S&P 500 Closes at 7,678 as Growth Leads on Quarter-Open Day
Profile
GeoVax is a clinical-stage biotechnology company which develops vaccines. GeoVax's development platform uses Modified Vaccinia Ankara vector technology, with improvements to antigen design and manufacturing capabilities. GeoVax uses recombinant DNA or recombinant viruses to produce virus-like particles in the person being vaccinated. Wikipedia
About Geovax Labs Inc
CEODavid A. Dodd
Employees19
Founded1988
HeadquartersAtlanta, Georgia, United States
SectorBiotechnology
Websitegeovax.com